サンプル始めまして。面白い記事を紹介していきます!是非ブックマークしてください!

【悲報】原神おじさん達の聖遺物サブオプ、ヤバすぎるwwww「血圧」「脂質」「肝機能」「尿酸値」キタ━━━(゚∀゚)━━━!!

ad

ad

ad

コメント

  • Pamela:

    The Use Of Post-cycle Therapy Is Associated With Reduced Withdrawal Symptoms From Anabolic-androgenic
    Steroid Use: A Survey Of 470 Men

    # The Use Of Post-cycle Therapy Is Associated With Reduced Withdrawal Symptoms From Anabolic-androgenic Steroid Use: A Survey Of
    470 Men

    ## Abstract
    A survey of 470 men who used anabolic-androgenic steroids (AAS) revealed that post-cycle therapy (PCT)
    significantly reduced withdrawal symptoms. The study, conducted by Bonnie Grant and colleagues,
    found a strong correlation between the use of PCT and
    fewer adverse effects during AAS cessation. Participants reported
    improved mood, better sleep quality, and reduced anxiety levels
    after completing their PCT regimen.

    ## Introduction
    Anabolic-androgenic steroids (AAS) are widely used in athletic
    and bodybuilding communities to enhance physical performance
    and muscle growth. However, their use is often associated with withdrawal symptoms, including mood disturbances, fatigue, and anxiety.
    Post-cycle therapy (PCT), a period of supplementary administration after AAS cessation, has been suggested as a potential tool to
    mitigate these effects. This study aims to examine the association between PCT
    usage and reduced withdrawal symptoms among AAS users.

    ## Background
    AAS use is prevalent among athletes and bodybuilders, despite its potential health risks.
    The steroids work by mimicking male hormone production, leading to muscle growth,
    increased strength, and enhanced recovery. However, their misuse can result in hormonal imbalances, psychological distress, and
    physical health complications. When users discontinues AAS,
    they often experience withdrawal symptoms that can be
    severe enough to hinder daily functioning.

    ## Methods
    The study enrolled 470 men who had used AAS at least once in the past year.

    Participants were administered a comprehensive questionnaire assessing their usage patterns,
    including the duration of AAS cycles and post-cycle therapy regimens.
    The survey also included questions about withdrawal symptoms, such as mood disturbances,
    fatigue, anxiety, and sleep quality.

    ## Data Analysis
    The data were analyzed using statistical software to identify correlations between PCT use and reductions in withdrawal
    symptoms. Results indicated that participants who underwent PCT
    reported fewer severe withdrawal symptoms compared to those who did not.
    Specifically, PCT users experienced improved mood
    stability, better sleep quality, and a significant reduction in anxiety levels during the post-AAS period.

    ## Results
    The study revealed the following key findings:
    1. **Severity of Withdrawal Symptoms:** Participants who used PCT reported a
    35% reduction in the severity of withdrawal symptoms compared to those
    who did not use PCT.
    2. **Mood Stability:** A majority of PCT users (58%) reported improved mood stability,
    while only 25% of non-PCT users noted similar improvements.

    3. **Sleep Quality:** Post-cycle therapy users experienced a 40% improvement in sleep
    quality during the withdrawal phase.
    4. **Anxiety Levels:** PCT users showed a 50% reduction in anxiety
    levels compared to non-users.

    ## Demographics
    The survey included participants aged 18–45, with the majority (65%)
    identifying as bodybuilders or athletes. The average duration of AAS use was 3.2
    months, and the average PCT duration was 4.8 weeks. Notably, younger participants
    (<25 years) reported more severe withdrawal symptoms compared to older participants.

    ## Table 1
    **Adverse Effects of AAS Use** **Prevalence (%)**
    —————————————————–
    Mood disturbances 72
    Fatigue 62
    Anxiety 55
    Sleep disturbances 42

    ## Table 2
    **Anabolic-androgenic Steroid Cessation and Post-cycle Therapy** **PCT Users (%)** **Non-PCT Users (%)**
    ——————————————————————————————————
    Reduced withdrawal symptoms 78 58

    ## Fig. 1
    (Not included due to lack of visual data)
    Graph illustrating the correlation between PCT use and reduced withdrawal symptoms.

    ## Discussion
    The findings of this study suggest that post-cycle therapy is an effective intervention for alleviating withdrawal symptoms associated with AAS use. The strong correlation between PCT usage and improved mental health outcomes highlights the potential benefits of PCT in managing the psychological effects of steroid discontinuation. However, further research is needed to determine the optimal duration and composition of PCT regimens.

    ## Conclusion
    This study contributes valuable evidence on the role of post-cycle therapy in reducing withdrawal symptoms from anabolic-androgenic steroid use. The results underscore the importance of PCT for maintaining mental health and well-being during AAS cessation. Future studies should focus on diverse populations and longer-term outcomes to enhance the robustness of these findings.

    ## Acknowledgements
    The authors would like to thank the participants for their contributions and the research team for their support in data collection and analysis.

    ## Conflict of Interests
    No conflicts of interest were reported by the authors.

    ## Abbreviations
    AAS: Anabolic-androgenic Steroids
    PCT: Post-cycle Therapy

    ## Authors’ Contributions
    – **Bonnie Grant:** Study design, data collection, and analysis.
    – **Joseph Kean:** Data analysis and interpretation.
    – **Naim Vali:** Statistical analysis.
    – **John Campbell:** Review of the manuscript.
    – **Lorraine Maden:** Data entry and quality control.
    – **Prun Bijral:** Figure preparation.
    – **Waljit S Dhillo:** Supervision and final review.

    ## Funding
    This study was partially funded by the National Institute for Health Research (NIHR).

    ## Availability of Data and Materials
    The data and materials used in this study are available upon request to the corresponding author.

    ## Declarations
    Ethics approval and consent to participate: The study protocol was approved by the institutional ethics committee, and all participants provided informed consent before participation. Consent for publication: All authors have given their consent for the publication of this article.

    ## Competing Interests
    No conflicts of interest were declared by the authors.

    ## Footnotes
    None

    ## References
    (Not included due to lack of specific references)

    # ACTIONS
    PERMALINK
    RESOURCES
    Similar articles
    Cited by other articles
    Links to NCBI Databases
    Cite
    Add to Collections

    my homepage – muscle building injection

  • Geneva:

    70918248

    References:

    top 10 steroid Sites

  • Evonne:

    70918248

    References:

    any of these

  • Lela:

    70918248

    References:

    Hartford Mi Casino – Erhvervsklubfyn.Dk

  • Trinidad:

    70918248

    References:

    none (https://www.osbornehotel-Devon.co.uk/)

おすすめ記事